Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, December 12, 2024
Almac Clinical Technologies, a member of the Almac Group, announced the acquisition of Your Research, a Netherlands-based clinical trial software company.
read more
Tuesday, December 10, 2024
Cellipont Bioservices and Xiogenix have announced a strategic partnership that enables Cellipont Bioservices to offer its clients access to the state-of-the-art Ares™ X20 fill and finish system, significantly enhancing the precision and efficiency of...
read more
Tuesday, December 10, 2024
Matica Biotechnology has announced a strategic partnerships with Treovir that aims to advance innovative therapies for pediatric patients with brain and other neurological cancers. Matica Bio will provide GMP manufacturing for clinical supplies.
read more
Tuesday, December 10, 2024
Dotmatics® and Databricks announced a strategic partnership to advance scientific discovery by leveraging the Dotmatics Luma™ Scientific Intelligence Platform.
read more
Tuesday, December 10, 2024
NorthStar Medical Radioisotopes, LLC, and PeptiDream Inc. announced that PeptiDream’s wholly owned subsidiary PDRadiopharma Inc. has entered into a strategic collaboration with NorthStar for the development, production, and commercialization of ...
read more
Thursday, December 05, 2024
Unlearn®, an artificial intelligence company, announced a partnership with German-based APST Research (APST), a platform for ALS clinical research.
read more
Thursday, December 05, 2024
Charles River Laboratories International, Inc. announced the launch of the Charles River Incubator Program (CIP), specializing in supporting early-stage biotechnology companies in the discovery, development and phase-appropriate manufacturing of ...
read more
Thursday, December 05, 2024
Cambrex, announced that it has signed an agreement with Eli Lilly and Company (Lilly) to deliver accelerated access to clinical development capabilities for Lilly's biotech collaborators.
read more
Thursday, December 05, 2024
LBB Specialties (LBBS) announced a strategic partnership with Clariant, a provider of specialty chemical manufacturing. Through this collaboration, LBB Specialties will distribute Clariant's pharmaceutical-grade high-functional excipients – including...
read more
Wednesday, December 04, 2024
Merck announced that the National Medical Products Administration (NMPA) in China has approved WELIREG® (belzutifan), for the treatment of adult patients with von Hippel-Lindau (VHL) disease who require therapy for associated renal cell carcinoma (...
read more
Wednesday, December 04, 2024
Univar Solutions LLC announced its selection as the sole channel partner for SD Head USA for the pharmaceutical industry across North America.
read more
Wednesday, December 04, 2024
N4 Pharma Plc announced a new lead program N4 101. This orally-delivered inflammation inhibitor for Irritable Bowel Disease (IBD) uses Nuvec®, the company’s novel silica non-viral, non-lipid nanoparticle delivery system, to overcome the challenges ...
read more
Tuesday, December 03, 2024
Sapio Sciences announced that evitria, a provider of antibody expression services, has selected Sapio’s Electronic Lab Notebook (ELN) and Sapio Report Builder to enhance its sample tracking, data capture, and reporting capabilities.
read more
Tuesday, December 03, 2024
BioDuro-Sundia, a contract research, development, and manufacturing organization, announced the appointment of Alan Findlater as Chief Commercial Officer.
read more
Tuesday, December 03, 2024
KBI Biopharma, Inc. announced a manufacturing contract with Alanis Therapeutics, Inc. (ATI) for the development of an innovative pre-clinical therapeutic antibody to treat myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) blood cancers...
read more